RedHill Biopharma financials at a glance

+ Portfolio

The revenue of RedHill Biopharma is reported as 0.0618 billion Dollars in the fiscal year 2023. The earnings were 0 Dollars per share in 2023, which was 0 higher than 2020. And about -0.02926 billion Dollars are reported as free cash flow in the financials of RedHill Biopharma 2023. No dividends were paid to the shareholders of the RedHill Biopharma stock NasdaqCM:RDHL in the financial year 2023.

Forecast

Financials

Year	Year	TTM	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Rev.	Revenue	N/A	$85.76M	$64.36M	$6.29M	$8.36M	$4.01M	$0.10M	$0.00M	$7.01M	$0.01M	$0.00M
GM %	Gross Margin %	42.74%	52.77%	43.92%	64.09%	66.06%	46.94%	100.00%	100.00%	85.03%	100.00%	100.00%
OM	Operating Margin	-78.01%	-84.23%	-97.71%	0.00%	0.00%	0.00%	0.00%	0.00%	-,151.80%	0.00%	0.00%
EPS	Earnings Per Share	$4.70	$-84.00	$-84.00	$-56.00	$-68.00	$-,104.00	$-92.00	$-76.00	$-48.00	$-6.80	$-8.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	-0.00%	0	-0.00%	0	0	0	0	0
Sha.	Shares	N/AM	1.32M	1.17M	0.88M	0.71M	0.53M	0.43M	0.32M	0.25M	0.22M	0.15M
OCF	Operating Cash Flow	N/A	$-65.05M	$-48.58M	$-40.75M	$-34.46M	$-44.77M	$-28.26M	$-17.83M	$-12.23M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-65.16M	$-48.99M	$-40.92M	$-34.49M	$-44.92M	$-28.82M	$-17.84M	$-12.30M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-10.66	$-1.40	$-2.81	$-1.38	$-1.49	$-2.60	$-2.21	$-1.76	$-1.54	$-1.39	$-1.31

RedHill Biopharma financials at a glance

Financials

Discover